Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04343482 · ClinicalTrials.gov registry record
Maternal Non-Stress Testing
A clinical trial of Pregnant Women, sponsored by Northwestern University.
- Completed
- Registry status
- 91
- Enrollment target
- 1
- Study location
NCT04343482: Completed study of Pregnant Women, sponsored by Northwestern University.
NCT04343482 is a study of Pregnant Women that has completed, run by Northwestern University. The registered enrollment target is 91 participants, below the 1,150-participant average among 5 other Pregnant Women trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04343482, a study of Pregnant Women, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
Primary Outcome
The primary outcome measure is concordance of FHR tracing assessments from Rogers sensor recordings with those obtained from the current standard of care electronic fetal monitoring systems.
Conditions Studied
Interventions
- DEVICE wearable vital signs sensor
Study Locations (1)
Illinois
- Northwestern Medicine Prentice Women's Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2022-09-06 |
What the finished NCT04343482 record still lists
NCT04343482 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,150-participant average among 5 other Pregnant Women trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Pregnant Women appearing as the primary indexed condition, and to 1 intervention - of which wearable vital signs sensor is the first listed.
NCT04343482 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04343482 about?
NCT04343482 is a clinical study titled "Maternal Non-Stress Testing". Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
What is the current status of trial NCT04343482?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2018-04-01. Estimated completion is 2022-09-06.
What conditions does trial NCT04343482 study?
This clinical trial studies the following conditions: Pregnant Women.
What interventions are being tested in trial NCT04343482?
The interventions under investigation include: wearable vital signs sensor (DEVICE).
Who is sponsoring clinical trial NCT04343482?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04343482 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnant Women
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Testing Effects of Melatonin on Uterine Contractions in Women
RECRUITING · NA
-
National Pregnancy Registry for Psychiatric Medications
RECRUITING
-
Prospective Cohort Study of HIV and Zika in Infants and Pregnancy
COMPLETED
-
Goals for Reaching Optimum Wellness (GROWell)
COMPLETED · NA
-
Home Visiting for Low Income, Pregnant Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI